TBXA2R Gene (Thromboxane A2 Receptor)

A key GPCR in platelet aggregation, vasoconstriction, and cardiovascular disease

Gene Information Card

Symbol TBXA2R
Full Name Thromboxane A2 Receptor
Gene Type protein-coding
Chromosomal Location 19p13.3
NCBI Gene ID 6915 ncbi.nlm.nih.gov/gene/6915
Ensembl ID ENSG00000106638
UniProt ID P21731
OMIM ID 188070
HGNC ID 11608
Aliases TXA2-R, TP, TPR

Description

The TBXA2R gene encodes the thromboxane A2 receptor, a G protein-coupled receptor (GPCR) that mediates the actions of thromboxane A2 (TXA2). This receptor is primarily expressed on platelets, vascular smooth muscle cells, and immune cells. Activation leads to platelet aggregation, vasoconstriction, and bronchoconstriction. TBXA2R is implicated in cardiovascular diseases, asthma, and thrombosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Asthma Receptor activation causes bronchoconstriction; polymorphisms may increase airway hyperresponsiveness ClinVar, OMIM
Thrombosis Enhanced platelet aggregation via Gq/PLC signaling; gain-of-function variants increase risk ClinVar, NCBI
Hypertension Vasoconstriction mediated by TP receptor in vascular smooth muscle OMIM, UniProt
Bleeding disorders Loss-of-function mutations impair platelet aggregation ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Blood (platelets) 8.2 Low
Spleen 6.1 Low
Vascular smooth muscle 4.3 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 0.2 Low expression
A549 (lung) 3.1 Moderate
HUVEC 1.5 Low
Megakaryocytes 7.8 High
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.924C>T (p.Arg308Cys) Missense <0.1% Reduced receptor activity; associated with bleeding tendency
c.795G>A (p.Trp265*) Nonsense <0.01% Loss of function; platelet aggregation defect
c.112G>A (p.Gly38Arg) Missense 0.2% Gain of function; increased risk of thrombosis
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Arg308Cys and p.Trp265* impair receptor signaling, leading to reduced platelet aggregation and bleeding disorders.

Gain of Function (GOF)

Variants like p.Gly38Arg enhance receptor activity, increasing platelet aggregation and thrombotic risk.

Dominant Negative (DN)

No dominant-negative mutations have been reported for TBXA2R.

Gene Ontology (GO)

• G protein-coupled receptor activity • thromboxane A2 receptor activity
• phospholipase C-activating G protein-coupled receptor signaling pathway • platelet activation
• vasoconstriction • inflammatory response

Pathways

Thromboxane A2 receptor signaling (Reactome: R-HSA-416476)
Platelet activation
signaling and aggregation (Reactome: R-HSA-76002)
GPCR downstream signaling (Reactome: R-HSA-388396)

Protein Summary

The thromboxane A2 receptor (TP) is a 343-amino acid GPCR with seven transmembrane domains. It couples primarily to Gq, activating phospholipase C and increasing intracellular calcium. TP exists in two splice variants: TPα and TPβ, which differ in the C-terminal tail and desensitization properties. The receptor is a target for antiplatelet drugs such as terutroban.

Related Products

Product name Cat.No. Species Gene ID
TBXA2R Knockout HEK293 Cell Line EDJ-KQ1604 Human 6915 Details Get a Quote
TBXA2R Knockout HCT 116 Cell Line EDJ-KQ21288 Human 6915 Details Get a Quote
TBXA2R Knockout HeLa Cell Line EDJ-KQ21289 Human 6915 Details Get a Quote
TBXA2R Knockout A-549 Cell Line EDJ-KQ63101 Human 6915 Details Get a Quote
TBXA2R Knockdown 4T1 stable cell line EDJ-KD007 Mouse 6915 Details Get a Quote
TBXA2R Knockout 4T1 Cell Line EDC07736 Mouse 21390 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: